Bulletin 2010/35 - European Patent Office
28.12.2012 • Views
Share Embed Flag

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(C12N) II.1(1)<br />

(54) • PHYTASE AUS DEBARYOMYCES CASTEL-<br />

LII<br />

• DEBARYOMYCES CASTELLII PHYTASE<br />

• PHYTASE DE DEBARYOMYCES CASTELLII<br />

(73) Adisseo France S.A.S., 42 avenue Aristide<br />

Briand, 92160 Antony, FR<br />

(72) BOZE, Hélène, F-34070 Montpellier, FR<br />

AUMELAS, André, F-34680 Saint Georges<br />

d'Orques, FR<br />

MOULIN, Guy, F-34980 Montferrier-sur-Lez,<br />

FR<br />

(74) Jouannic, Nathalie, et al, Cabinet Germain &<br />

Maureau BP 6153, 69466 Lyon Cedex 06, FR<br />

C12N 9/18 → (51) C12N 15/55<br />

C12N 15/00 → (51) C07K 14/08<br />

C12N 15/00 → (51) C12Q 1/48<br />

(51) C12N 15/09 (11) 1 318 194 B1<br />

C12Q 1/02 C12Q 1/48<br />

G01N 33/15 G01N 33/50<br />

G01N 33/66 G01N 33/68<br />

(25) Ja (26) En<br />

(21) 0196<strong>35</strong>86.1 (22) 11.09.2001<br />

(84) DE ES FR GB IT<br />

(43) 11.06.2003<br />

(86) JP 2001/007879 11.09.2001<br />

(87) WO 2002/022813 2002/12 21.03.2002<br />

(30) 11.09.2000 JP 2000274531<br />

(54) • VERFAHREN ZUM SCREENING EINER<br />

HYPOGLYKÄMISCHEN SUBSTANZ DURCH<br />

VERWENDUNG DES STAT HEMMENDEN<br />

FAKTORS-1<br />

• METHOD OF SCREENING HYPOGLYCEMIC<br />

SUBSTANCE BY USING STAT INHIBITORY<br />

FACTOR-1<br />

• PROCEDE DE CRIBLAGE DE SUBSTANCES<br />

HYPOGLYCEMIANTES A L'AIDE DU FAC-<br />

TEUR INHIBITEUR STAT 1<br />

(73) Kishimoto, Tadamitsu, 3-5-31, Nakano-cho,<br />

Tondabayashi-shi, Osaka 584-0021, JP<br />

(72) KISHIMOTO, Tadamitsu, Tondabayashi-shi,<br />

Osaka 584-0021, JP<br />

NAKA, Tetsuji, Toyonaka-shi, Osaka 560-<br />

0045, JP<br />

(74) Henkel, Feiler & Hänzel, <strong>Patent</strong>anwälte Maximiliansplatz<br />

21, 80333 München, DE<br />

(51) C12N 15/09 (11) 1 403 368 B1<br />

C07K 14/47 C07K 16/18<br />

C12N 5/10 C12Q 1/02<br />

C12Q 1/68 C12P 21/08<br />

G01N 33/68<br />

(25) Ja (26) En<br />

(21) 02774069.5 (22) 27.05.2002<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 31.03.2004<br />

(86) JP 2002/005095 27.05.2002<br />

(87) WO 2002/097088 2002/49 05.12.2002<br />

(30) 29.05.2001 JP 2001161212<br />

(54) • TESTIKULÄRER CARNITINTRANSPORTER<br />

UND SEIN GEN<br />

• TESTICULAR CARNITINE TRANSPORTER<br />

AND ITS GENE<br />

• TRANSPORTEUR DE CARNITINE TESTI-<br />

CULAIRE ET SON GENE<br />

(73) Human Cell Systems, Inc., Shinjuku-Hokuto<br />

Building 5F, 6-8, Shinjuku 2-chome, Shinjuku-ku<br />

Tokyo 1600022, JP<br />

(72) ENDOU, Hitoshi, Sagamihara-shi, Kanagawa<br />

229-0022, JP<br />

KANAI, Yoshikatsu, Toyonaka-shi, Osaka<br />

560-0005, JP<br />

ENOMOTO, Atsushi, Nishio-shi, Aichi 445-<br />

0054, JP<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(74) Benson, John Everett, et al, J. A. Kemp & Co.<br />

14 South Square Gray's Inn, London WC1R<br />

5JJ, GB<br />

(51) C12N 15/09 (11) 1 867 716 B1<br />

A01K 67/027 C12N 1/15<br />

C12N 1/19 C12N 1/21<br />

C12N 5/10 C12Q 1/68<br />

(25) Ja (26) En<br />

(21) 06728869.6 (22) 10.03.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 19.12.2007<br />

(86) JP 2006/304701 10.03.2006<br />

(87) WO 2006/095846 2006/37 14.09.2006<br />

(30) 11.03.2005 JP 2005069013<br />

(54) • TIERMODELL MIT IN ECHTZEIT<br />

BEOBACHTBAREM KRANKHEITSZU-<br />

STAND, GENKONSTRUKT ZUR HERSTEL-<br />

LUNG DAVON UND VERWENDUNG DAVON<br />

• MODEL ANIMAL IN WHICH STATE OF<br />

DISEASE CONDITION IS OBSERVABLE IN<br />

REAL TIME, GENE CONSTRUCT FOR<br />

ACHIEVING THE SAME AND USE OF THE<br />

SAME<br />

• ANIMAL MODELÉ DANS LEQUEL L'ÉVO-<br />

LUTION D'UN ÉTAT PATHOLOGIQUE PEUT<br />

ÊTRE OBSERVÉ EN TEMPS RÉEL, GÈNE<br />

CHIMÈRE UTILISÉ POUR CE FAIRE ET<br />

UTILISATION CORRESPONDANTE<br />

(73) Nano Factory Co., Ltd., 18, Okazakikitagosyo-cho,<br />

Sakyo-ku Kyoto 606-8336, JP<br />

(72) KONDOH, Shinae, c/o Graduate School of<br />

Medicine, Kyoto-shi, Kyoto, 6068501, JP<br />

HARADA, Hiroshi, c/o Graduate School of<br />

Medicine, Kyoto-shi, Kyoto, 6068501, JP<br />

HIRAOKA, Masahiro, c/o Graduate School of<br />

Medicine, Kyoto-shi, Kyoto, 6068501, JP<br />

YAMADA, Shu-ichi, Iwamizawa-shi Hokkaido<br />

0690381, JP<br />

(74) Barz, Peter, <strong>Patent</strong>anwalt Kaiserplatz 2,<br />

80803 München, DE<br />

C12N 15/09 → (51) C12N 15/62<br />

C12N 15/10 → (51) C12Q 1/68<br />

(51) C12N 15/11 (11) 1 458 863 B1<br />

A61P <strong>35</strong>/00 A61K 48/00<br />

A61K 31/713 C12Q 1/68<br />

(25) En (26) En<br />

(21) 02788185.3 (22) 19.12.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GR<br />

IE IT LI LU MC NL PT SE SI SK TR<br />

(43) 22.09.2004<br />

(86) GB 2002/005802 19.12.2002<br />

(87) WO 2003/056012 2003/28 10.07.2003<br />

(30) 24.12.2001 GB 0130955<br />

02.05.2002 US 377482 P<br />

09.08.2002 GB 0218556<br />

09.08.2002 US 216054<br />

(54) • EIN SYSTEM ZUR STABILEN EXPRESSION<br />

VON SIRNAS IN SÄUGETIERZELLEN<br />

• A SYSTEM FOR STABLE EXPRESSION OF<br />

SIRNAS IN MAMMALIAN CELLS<br />

• SYSTEME D'EXPRESSION STABLE<br />

D'ARNSI DANS DES CELLULES DE MAM-<br />

MIFERES<br />

(73) Cancer Research Technology Limited, 61<br />

Lincoln's Inn Fields, London WC2A 3PX, GB<br />

(72) AGAMI, Reuven, The Netherlands Cancer<br />

Institute, NL-1066 CX Amsterdam, NL<br />

BRUMMELKAMP, Thijn, The Netherlands<br />

Cancer Inst., NL-1066 CX Amsterdam, NL<br />

(74) Lee, Nicholas John, et al, Kilburn & Strode<br />

LLP 20 Red Lion Street, London WC1R 4PJ,<br />

GB<br />

599<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>35</strong>/<strong>2010</strong>) 01.09.<strong>2010</strong><br />

(51) C12N 15/11 (11) 2 064 328 B1<br />

C12P 19/34 C07H 21/02<br />

C07H 21/04 A01N 43/04<br />

A61K 31/713<br />

(25) En (26) En<br />

(21) 07825533.8 (22) 23.07.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(43) 03.06.2009<br />

(86) IB 2007/003269 23.07.2007<br />

(87) WO 2008/015577 2008/06 07.02.2008<br />

(30) 31.07.2006 EP 06291241<br />

(54) • SENSIBILISIERUNG VON KREBSZELLEN<br />

FÜR EINE THERAPIE UNTER VERWEN-<br />

DUNG VON SINA-ZIELGENEN AUS DEN<br />

CHROMOSOMENREGIONEN 1P UND 19Q<br />

• SENSITIZATION OF CANCER CELLS TO<br />

THERAPY USING SINA TARGETING<br />

GENES FROM THE 1P AND 19Q CHRO-<br />

MOSOMAL REGIONS<br />

• SENSIBILISATION DES CELLULES DE<br />

CANCER À LA THÉRAPIE EN UTILISANT<br />

LE SINA VISANT DES GÈNES DES<br />

RÉGIONS 1P ET 19Q CHROMOSOMIQUES<br />

(73) Universite Joseph Fourier (Grenoble 1), 621<br />

Avenue Centrale Domaine Universitaire de<br />

Saint-Martin d'Heres, 38041 Grenoble Cedex<br />

9, FR<br />

(72) BERGER, François, F-38240 Meylan, FR<br />

PELLETIER, Laurent, F-38130 Echirolles, FR<br />

ISSARTEL, Jean-Paul, F-38120 St Egreve, FR<br />

BOCCARD, Sandra, F-38920 Crolles, FR<br />

(74) Grosset-Fournier, Chantal Catherine, et al,<br />

Grosset-Fournier & Demachy 54, rue Saint-<br />

Lazare, 75009 Paris, FR<br />

(60) 10167455.4<br />

C12N 15/11 → (51) C07H 21/00<br />

C12N 15/11 → (51) C07K 7/06<br />

(51) C12N 15/113 (11) 1 605 978 B1<br />

C07H 21/00<br />

(25) En (26) En<br />

(21) 04718537.6 (22) 08.03.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

(43) 21.12.2005<br />

(86) US 2004/007070 08.03.2004<br />

(87) WO 2004/080406 2004/39 23.09.2004<br />

(30) 07.03.2003 US 452682 P<br />

12.03.2003 US 454265 P<br />

13.03.2003 US 454962 P<br />

13.03.2003 US 455050 P<br />

14.04.2003 US 462894 P<br />

17.04.2003 US 463772 P<br />

25.04.2003 US 465665 P<br />

25.04.2003 US 465802 P<br />

09.05.2003 US 469612 P<br />

08.08.2003 US 493986 P<br />

11.08.2003 US 494597 P<br />

26.09.2003 US 506341 P<br />

09.10.2003 US 510246 P<br />

10.10.2003 US 510318 P<br />

07.11.2003 US 518453 P<br />

(54) • THERAPEUTISCHE ZUSAMMENSETZUN-<br />

GEN<br />

• THERAPEUTIC COMPOSITIONS<br />

• COMPOSITIONS THERAPEUTIQUES<br />

(73) Alnylam Pharmaceuticals Inc., 790 Memorial<br />

Drive, Suite 202, Cambridge, MA 02139, US<br />

(72) MANOHARAN, Muthiah, Weston, MA 02493,<br />

US<br />

(74) Müller-Boré & Partner <strong>Patent</strong>anwälte, Grafinger<br />

Straße 2, 81671 München, DE

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!